A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

The purpose of this study is to examine the safety, tolerability, and PK of various increasing single and multiple doses of VBP15 in healthy adult subjects.

Key facts

Study ID

NCT02415439

Run by

ReveraGen BioPharma, Inc.

People needed

86

Starts

2015-01-01

Expected to finish

2016-05-01

Last updated by the study team

2017-03-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• For the Single Ascending Dose Study (SAD): Male subjects, ages 18 to 65 years, inclusive.
• For the Multiple Ascending Dose Study (MAD): Male subjects or female subjects of nonchildbearing potential ages 18 to 65, inclusive.

You may not qualify if…

• For the MAD Study: Women of childbearing potential.
• Clinically significant abnormal laboratory parameters

Where it is running

• PRA Health Sciences — Lenexa, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.